EYErin A. Yamamoto

Erin A. Yamamoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Erin A. Yamamoto has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nationwide and Regional Trends in Surgical Outcomes After Posterior Lumbar Interbody Fusion Over an 11-Year Period

    by Lauren A. Nguyen, Erin A. Yamamoto, Maryam N. Shahin, Josiah N. Orina, Clifford Lin, Jung Yoo, Won Hyung Ryu

    Study Design: Retrospective cohort study. Objective: To examine national and regional trends in preoperative patient optimization and surgical outcomes among patients undergoing posterior lumbar interbody fusion (PLIF) in the United States from 2011 to 2022. Methods: Patients who underwent PLIF were identified in the PearlDiver Patient Claims Database using ICD-9, ICD-10 and CPT codes. Demographic characteristics, comorbidities, and postoperative outcomes were analyzed over 11 years and by U.S. region (Midwest, Northeast, South, West). Variables included age, body mass index, tobacco use, Charlson Comorbidity Index (CCI), opioid use, 30-day complications, 90-day readmissions, infection, and hospital length of stay (LOS). Statistical analysis was performed using R (α = 0.05). Results: 434 214 patients underwent PLIF from 2011 to 2022. Nationally, LOS, 30-day complication, and 90-day readmission worsened over time. Hospital LOS increased ( P < .0001) and infection rate decreased for all regions ( P < .001). The Northeast showed significant improvement, whereas the South, Midwest and West all had rising complications and readmissions. Patients in 2021-2022 were older, with more comorbidities, more likely to use tobacco, and had higher rates of overweight and obesity. Significant decreases were observed in preoperative opioid use ( P < .0001). Conclusions: Despite an emphasis on preoperative optimization and demonstrated reductions in preoperative opiate use, surgical outcomes including 30-day complications, 90-day readmissions, and length of stay increased in recent years. Worsening outcomes imply potential gaps in optimization efforts and regional outcome variability may suggest a need for region-specific preoperative optimization strategies.


  • Biological Sex and Body Mass Index Influence the Longitudinal Evolution of Adolescent and Young Adult Magnetic Resonance Imaging-Visible Perivascular Spaces

    by Erin A. Yamamoto, Seiji Koike, Caitlyn Wong, Laura E. Dennis, Madison N. Luther, Avery Scatena, Seva Khambadkone, Jeffrey J. Iliff, Miranda M. Lim, Swati R. Levendovszky, et al.


  • Top Cited Papers
    Open Access

    The perivascular space is a conduit for cerebrospinal fluid flow in humans: A proof-of-principle report

    by Erin A. Yamamoto, Jacob H. Bagley, Mathew Geltzeiler, Olabisi R. Sanusi, Aclan Dogan, Jesse J. Liu, Juan Piantino

    The glymphatic pathway was defined in rodents as a network of perivascular spaces (PVSs) that facilitates organized distribution of cerebrospinal fluid (CSF) into the brain parenchyma. To date, perivascular CSF and cerebral interstitial fluid exchange has not been shown in humans. Using intrathecal gadolinium contrast-enhanced MRI, we show that contrast-enhanced CSF moves through the PVS into the parenchyma, supporting the existence of a glymphatic pathway in humans.


  • Open Access

    Biological sex and BMI influence the longitudinal evolution of adolescent and young adult MRI-visible perivascular spaces

    by Erin A. Yamamoto, Seiji Koike, Caitlyn Wong, Laura E. Dennis, Madison N. Luther, Avery Scatena, Seva Khambadkone, Jeffrey J. Iliff, Miranda M. Lim, Swati R. Levendovszky, et al.

    Background and Purpose: An association recently emerged between magnetic resonance imaging (MRI)-visible perivascular spaces (MV-PVS) with intracerebral solute clearance and neuroinflammation, in adults. However, it is unknown how MV-PVS change throughout adolescence and what factors influence MV-PVS volume and morphology. This study assesses the temporal evolution of MV-PVS volume in adolescents and young adults, and secondarily evaluates the relationship between MV-PVS, age, sex, and body mass index (BMI). Materials and Methods: This analysis included a 783 participant cohort from the longitudinal multicenter National Consortium on Alcohol and Neurodevelopment in Adolescence study that involved up to 6 imaging visits spanning 5 years. Healthy adolescents aged 12-21 years at study entry with at least two MRI scans were included. The primary outcome was mean MV-PVS volume (mm 3 /white matter cm 3 ). Results: On average, males had greater MV-PVS volume at all ages compared to females. A linear mixed-effect model for MV-PVS volume was performed. Mean BMI and increases in a person’s BMI were associated with increases in MV-PVS volume over time. In females only, changes in BMI correlated with MV-PVS volume. One unit increase in BMI above a person’s average BMI was associated with a 0.021 mm 3 /cm 3 increase in MV-PVS volume (p<0.001). Conclusion: This longitudinal study showed sex differences in MV-PVS features during adolescence and young adulthood. Importantly, we report that increases in BMI from a person’s mean BMI are associated with increases in MV-PVS volume in females only. These findings suggest a potential link between MV-PVS, sex, and BMI that warrants future study.


  • Perivascular Space Burden and Cerebrospinal Fluid Biomarkers in US Veterans With Blast-Related Mild Traumatic Brain Injury

    by Erin A. Yamamoto, Seiji Koike, Madison Luther, Laura Dennis, Miranda M. Lim, Murray Raskind, Kathleen Pagulayan, Jeffrey Iliff, Elaine Peskind, Juan A. Piantino

    Blast-related mild traumatic brain injury (mTBI) is recognized as the “signature injury” of the Iraq and Afghanistan wars. Sleep disruption, mTBI, and neuroinflammation have been individually linked to cerebral perivascular space (PVS) dilatation. Dilated PVSs are putative markers of impaired cerebrospinal fluid (CSF) and interstitial fluid exchange, which plays an important role in removing cerebral waste. The aim of this cross-sectional, retrospective study was to define associations between biomarkers of inflammation and MRI-visible PVS (MV-PVS) burden in Veterans after blast-related mTBI (blast-mTBI) and controls. The CSF and plasma inflammatory biomarker concentrations were compared between blast-mTBI and control groups and correlated with MV-PVS volume and number per white matter cm 3 . Multiple regression analyses were performed with inflammatory biomarkers as predictors and MV-PVS burden as the outcome. Correction for multiple comparisons was performed using the Banjamini-Hochberg method with a false discovery rate of 0.05. There were no group-wise differences in MV-PVS burden between Veterans with blast-mTBI and controls. Greater MV-PVS burden was significantly associated with higher concentrations of several proinflammatory biomarkers from CSF (i.e., eotaxin, MCP-1, IL-6, IL-8) and plasma (i.e., MCP-4, IL-13) in the blast-mTBI group only. After controlling for sleep time and symptoms of post-traumatic stress disorder, temporal MV-PVS burden remained significantly associated with higher CSF markers of inflammation in the blast-mTBI group only. These data support an association between central, rather than peripheral, neuroinflammation and MV-PVS burden in Veterans with blast-mTBI independent of sleep. Future studies should continue to explore the role of blast-mTBI related central inflammation in MV-PVS development, as well as investigate the impact of subclinical exposures on MV-PVS burden.


  • Characterizing utilization patterns and reoperation risk factors of interspinous process devices: analysis of a national claims database

    by Hao Tan, Erin A Yamamoto, Spencer Smith, Jung Yoo, Jonathan Kark, Clifford Lin, Josiah Orina, Travis Philipp, Donald A Ross, Christina Wright, et al.

    Introduction: Interspinous process devices (IPDs) were developed as minimally invasive alternatives to open decompression surgery for spinal stenosis. However, given high treatment failure and reoperation rates, there has been minimal adoption by spine surgeons. This study leveraged a national claims database to characterize national IPD usage patterns and postoperative outcomes after IPD implantation. Method: Using the PearlDiver database, we identified all patients who underwent 1- or 2-level IPD implantation between 2010 and 2018. Univariate and multivariable logistic regression was performed to identify predictors of the number of IPD levels implanted and reoperation up to 3 years after the index surgery. Right-censored Kaplan-Meier curves were plotted for duration of reoperation-free survival and compared with log-rank tests. Results: Patients (n = 4865) received 1-level (n = 3246) or 2-level (n = 1619) IPDs. Patients who were older (adjusted odds ratio [aOR] 1.02, 95% confidence interval [CI] 1.01–1.03, P < .001), male (aOR 1.31, 95% CI 116–1.50, P < .001), and obese (aOR 1.19, 95% CI 1.05–1.36, P < .01) were significantly more likely to receive a 2-level IPD than to receive a 1-level IPD. The 3-year reoperation rate was 9.3% of patients when mortality was accounted for during the follow-up period. Older age decreased (aOR 0.97, 95% CI 0.97–0.99, P = .0039) likelihood of reoperation, whereas 1-level IPD (aOR 1.37, 95% CI 1.01–1.89, P = .048), Charlson Comorbidity Index (aOR 1.07, 95% CI 1.01–1.14, P = .018), and performing concomitant open decompression increased the likelihood of reoperation (aOR 1.68, 95% CI 1.35–2.09, P = .0014). Conclusion: Compared with 1-level IPDs, 2-level IPDs were implanted more frequently in older, male, and obese patients. The 3-year reoperation rate was 9.3%. Concomitant open decompression with IPD placement was identified as a significant risk factor for subsequent reoperation and warrants future investigation.


  • Venous Sinus Stenting: Safety and Health Care Resource Evaluation for Optimal Recovery in an Evolving Health Care Environment

    by David J. Mazur-Hart, Erin A. Yamamoto, Christian G. Lopez Ramos, Matthew K. McIntyre, Brandi W. Pang, Daniel N. Munger, Jacob H. Bagley, Aclan Dogan, Hormozd Bozorgchami, Gary M. Nesbit, et al.


  • Open Access

    Low Levels of Vitamin D Promote Memory B Cells in Lupus

    by Erin A. Yamamoto, Jane K. Nguyen, Jessica Liu, Emma Keller, Nicole Campbell, Cun-Jin Zhang, Howard R. Smith, Xiaoxia Li, Trine N Jørgensen

    Background: Vitamin D deficiency is a known risk factor for Systemic Lupus Erythematosus (SLE), yet clinical trials have not demonstrated efficacy and few studies have utilized lupus models to understand the mechanism underlying this relationship. The Act1-/- mouse is a spontaneous model of lupus and Sjögren’s syndrome, characterized by increased Th17 cells and peripheral B cell expansion. Vitamin D3 has anti-inflammatory properties, reduces Th17 cells and impairs B cell differentiation/activation. Therefore, we assessed how varying amounts of vitamin D3 affected lupus-like disease in the Act1-/- mouse. Methods: Act1-/- mice were fed either low/restricted (0 IU/kg), normal (2 IU/kg), or high/supplemented (10 IU/kg) vitamin D3 chow for 9 weeks, after which lupus-like features were analyzed. Results: While we found no differences in Th17 cells between vitamin D3 groups, vitamin D3 restriction specifically promoted memory B cell development, accompanied by elevated levels of serum IgM, IgG1, IgG3, and anti-dsDNA IgG. A similar significant negative association between serum vitamin D and memory B cells was confirmed in a cohort of SLE patients. Conclusion: Low levels of vitamin D3 are associated with elevated levels of memory B cells in an animal model of lupus and well-controlled SLE patients.


  • Top Cited Papers
    Open Access

    Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity

    by Erin A. Yamamoto, Trine N. Jørgensen

    There is increasing recognition of the role the microbiome plays in states of health and disease. Microbiome studies in systemic autoimmune diseases demonstrate unique microbial patterns in Inflammatory Bowel Disease, Rheumatoid Arthritis, and Systemic Lupus Erythematosus to a lesser extent, whereas there is no single bug or pattern that characterizes Multiple Sclerosis. Autoimmune diseases tend to share a predisposition for vitamin D deficiency, which alters the microbiome and integrity of the gut epithelial barrier. In this review, we summarize the influence of intestinal bacteria on the immune system, explore the microbial patterns that have emerged from studies on autoimmune diseases, and discuss how vitamin D deficiency may contribute to autoimmunity via its effects on the intestinal barrier function, microbiome composition, and/or direct effects on immune responses.